Medical School, Kunming University of Science and Technology, Kunming, Yunnan Province 650500, China.
Medical School, Kunming University of Science and Technology, Kunming, Yunnan Province 650500, China.
Int Immunopharmacol. 2019 Feb;67:335-347. doi: 10.1016/j.intimp.2018.12.013. Epub 2018 Dec 19.
Chronic obstructive pulmonary disease (COPD) is characterized by a progressive and irreversible airflow obstruction, with an abnormal lung function. The etiology of COPD correlates with complex interactions between environmental and genetic determinants. However, the exact pathogenesis of COPD is obscure although it involves multiple aspects including oxidative stress, imbalance between proteolytic and anti-proteolytic activity, immunity and inflammation, apoptosis, and repair and destruction in both airways and lungs. Many genes have been demonstrated to be involved in those pathogenic processes of this disease in patients exposed to harmful environmental factors. Previous reports have investigated promising microRNAs (miRNAs) to disclose the molecular mechanisms for COPD development induced by different environmental exposure and genetic predisposition encounter, and find some potential miRNA biomarkers for early diagnosis and treatment targets of COPD. In this review, we summarized the expression profiles of the reported miRNAs from studies of COPD associated with environmental risk factors including cigarette smoking and air pollution exposures, and provided an overview of roles of those miRNAs in the pathogenesis of the disease. We also highlighted the potential utility and limitations of miRNAs serving as diagnostic biomarkers and therapeutic targets for COPD.
慢性阻塞性肺疾病(COPD)的特征是进行性和不可逆转的气流阻塞,伴有异常的肺功能。COPD 的病因与环境和遗传决定因素之间的复杂相互作用有关。然而,尽管 COPD 的发病机制涉及氧化应激、蛋白水解和抗蛋白水解活性失衡、免疫和炎症、细胞凋亡以及气道和肺部的修复和破坏等多个方面,但仍不清楚。许多基因已被证明参与了暴露于有害环境因素的患者的这些疾病的发病机制。先前的研究已经调查了有前途的 microRNAs(miRNAs),以揭示不同环境暴露和遗传易感性所诱导的 COPD 发展的分子机制,并找到了一些用于 COPD 早期诊断和治疗靶点的潜在 miRNA 生物标志物。在这篇综述中,我们总结了与环境危险因素(包括吸烟和空气污染暴露)相关的 COPD 研究中报道的 miRNAs 的表达谱,并概述了这些 miRNAs 在疾病发病机制中的作用。我们还强调了 miRNA 作为 COPD 诊断生物标志物和治疗靶点的潜在用途和局限性。